Femme Homme
- | Pays :
- Canada
- Poland
- Ukraine
- Les 8 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a randomized, open-label, multinational, phase III study in women with histologically- or cytologically-confirmed advanced NSCLC who are chemotherapy naïve and have PS 2. Study drug will be administered on day 1 of each 21 day cycle
Critère d'inclusion
- NSCLC